A legacy that inspires the Future.

For over half a century, Cordis has connected and collaborated across the industry, with a mission to invent better ways to serve clinicians and their collaborators. As a global leader in breakthrough cardiovascular and endovascular solutions, we are the people behind the people who keep saving lives.

Imagine

Imagine

Cordis: Imagine This. At the center of our passion for advancing cardiovascular and endovascular health are the clinicians and collaborators on the frontlines. They inspire us each and every day with their commitment to continuously move the needle. As we celebrate one year of independence, we are even more proud than we were 62 years ago to stand behind the heroes that allow us all to be truly free at heart.

News

Oct 17, 2022

Cordis Announces Acquisition of MedAlliance

Cordis Announces Acquisition of MedAlliance, Positioning Itself for Market Leadership in Drug-Eluting Balloon Technology

Read more

Jul 11, 2022

Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe

Multi-center study to evaluate safety and efficacy of S.M.A.R.T. RADIANZ™ Vascular Stent System via Radial Access

Read more

Jul 8, 2022

Cordis Names Bryan Loo President Of The Asia-Pacific Region

Bryan Loo will head a leadership team responsible for the fast-growing APAC region for Cordis.

Read more

Highlights

RAIN Sheath™ Transradial Thin-walled Introducer

The RAIN Sheath™ Transradial Thin-walled Introducer brings innovation in your hands with KINK RECOVERY TECHNOLOGY™. The proprietary sheath with elastomeric properties is designed to maintain lumen integrity.

Discover More

RAILWAY™ Sheathless Access System

The RAILWAY™ Sheathless Access System is a versatile system for reducing access up to 2F1. This system features a smaller access profile than any radial sheath, and compatibility with a variety of guiding catheters.

1 Compared to conventional radial sheaths. Profile reduction is 1.2F compared to Terumo Glidesheath Slender.

Discover More

MYNX CONTROL™ Vascular Closure Device

Closes with security. Leave nothing behind*. MYNX CONTROL™ Vascular Closure Devices integrate dual-mode active sealing and resorbability with a next-generation delivery system to maximize predictability, safety and ease of use.

* The sealant is resorbed by the body within 30 days

Discover More

Driven by mission, guided by values

Cordis is making a difference. We impact millions of lives, in more than 60 countries around the world. We embrace a diverse, empowered culture where teammates are inspired to serve customers, patients and shareholders while fulfilling their own career aspirations.

Need Help?

We’re here with the support and information to help you make the right decision for your patients.